Barnett & Company’s Bausch Health BHC Stock Holding History

Barnett & Company’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100	Closed	-$2K	–	310
2017 Q4	$2K	Buy	+100	New	+$1.59K	﹤0.01%	305

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barnett & Company's BHC Position: Q1 2018 in Review

Barnett & Company sold out of Bausch Health (BHC) in Q1 2018, closing a stake of 100 shares — an estimated $2K sold.

Barnett & Company first reported a position in BHC in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 327 funds tracked by Wall St. Rank hold BHC as of Q1 2018.

Barnett & Company reported no remaining Bausch Health position as of Q1 2018 after selling out during the quarter.
Barnett & Company sold 100 Bausch Health shares in Q1 2018, an estimated $2K.
Barnett & Company first reported a position in Bausch Health in Q4 2017 and held it in 1 quarter.
Barnett & Company's Bausch Health position peaked at $2K in Q4 2017.
327 funds tracked by Wall St. Rank held Bausch Health as of Q1 2018.

Based on Barnett & Company's 13F filing for Q1 2018, filed 14 May 2018.